Popular
Mechanism of Action for Aryl Hydrocarbon Receptor Agonists
Practical DermatologyMechanism of Action for Aryl Hydrocarbon Receptor Agonists
Neal Bhatia, MD, FAAD
Joshua Grosshandler, MD, FAAD
Tapinarof’s Place in Inflammatory Disease Treatment
Practical DermatologyTapinarof’s Place in Inflammatory Disease Treatment
Neal Bhatia, MD, FAAD
Joshua Grosshandler, MD, FAAD
Skin Barrier Maintenance in Atopic Dermatitis and Psoriasis
Practical DermatologySkin Barrier Maintenance in Atopic Dermatitis and Psoriasis
Neal Bhatia, MD, FAAD
Joshua Grosshandler, MD, FAAD
Managing Patient Expectations with Topical Therapies
Practical DermatologyManaging Patient Expectations with Topical Therapies
Neal Bhatia, MD, FAAD
Joshua Grosshandler, MD, FAAD
Various Benefits of Aryl Hydrocarbon Receptor Agonists
Practical DermatologyVarious Benefits of Aryl Hydrocarbon Receptor Agonists
Neal Bhatia, MD, FAAD
Joshua Grosshandler, MD, FAAD
ADORING Trials Show Broad Efficacy, Early Itch Relief
Practical DermatologyADORING Trials Show Broad Efficacy, Early Itch Relief
Jonathan Silverberg, MD, PhD, MPH
Programs
Tapinarof’s Place in Inflammatory Disease Treatment
Practical DermatologyTapinarof’s Place in Inflammatory Disease Treatment
Neal Bhatia, MD, FAAD
Joshua Grosshandler, MD, FAAD
Naiem T. Issa, MD, PhD, FAAD
Maureen N. Offiah, MD, FAAD
Why Lower-Frequency Dosing Can Be Helpful in Atopic Dermatitis
Practical DermatologyWhy Lower-Frequency Dosing Can Be Helpful in Atopic Dermatitis
Naiem T. Issa, MD, PhD, FAAD
Maureen N. Offiah, MD, FAAD
Beyond Skin Clearance: What Patient-Reported Outcomes Reveal in Atopic Dermatitis
Practical Dermatology: Updates in Atopic DermatitisBeyond Skin Clearance: What Patient-Reported Outcomes Reveal in Atopic Dermatitis
G. Michael Lewitt, MD
Treatment Challenges with Chronic Atopic Dermatitis
Practical DermatologyTreatment Challenges with Chronic Atopic Dermatitis
Naiem T. Issa, MD, PhD, FAAD
Maureen N. Offiah, MD, FAAD
Clinical Practice
Continuous Glucose and Ketone Monitoring: Making Smarter Decisions in Diabetes
CME/CEContinuous Glucose and Ketone Monitoring: Making Smarter Decisions in Diabetes
Stephen Brunton, MD, FAAFP, CDCES
James R. Gavin III, MD, PhD
Davida F. Kruger, MSN, APN-BC, BC-ADM
Eden Miller, DO, D-ACD, D-ABOM
Navigating Severe Asthma Together: A Patient-Clinician Conversation
Deep Breaths: Updates from CHESTNavigating Severe Asthma Together: A Patient-Clinician Conversation
Diego Maselli, MD, FCCP
Translating Evidence Into Practice: Myosin Inhibition Across the HCM Spectrum
CME/CETranslating Evidence Into Practice: Myosin Inhibition Across the HCM Spectrum
Christian Schulze, MD, PhD
Ahmad Masri, MD, MS
Michelle Michels, MD
Individualizing Management Strategies for PSVT: Incorporating Patient Preference
MinuteCE®Individualizing Management Strategies for PSVT: Incorporating Patient Preference
Jennifer Carlquist, PA-C
Sean Pokorney, MD, MBA
Brian P. Rose, PA-C, MPH
- CME/CE In-Person & Virtual Event
Spotlight on B7-H3 ES-SCLC: Applying ADC Evidence in Real-World Practice
December 5, 2026
Scottsdale, Arizona The New Era of Targeted Therapy for Myasthenia Gravis
NeuroFrontiersThe New Era of Targeted Therapy for Myasthenia Gravis
Shruti Raja, MD, MHS
Doctors Lounge
Earlier Detection, Smarter Prevention: AI-Powered Alzheimer's Care
The ConvergenceEarlier Detection, Smarter Prevention: AI-Powered Alzheimer's Care
Brian P. McDonough, MD, FAAFP
Adrian Noriega de la Colina, MD, PhD
Arvid E. Gollwitzer
Bruno Batinica, MD
Advancing ATTR-CM Identification: Early Findings from TRACE-AI
Heart MattersAdvancing ATTR-CM Identification: Early Findings from TRACE-AI
Bruno Batinica, MD
Humanoids in Healthcare: Extending the Reach of Surgical Expertise
The ConvergenceHumanoids in Healthcare: Extending the Reach of Surgical Expertise
Brian P. McDonough, MD, FAAFP
Michael Yip, PhD
The Science of Exceptions: Setting the Safety Bar for Clinical AI
The ConvergenceThe Science of Exceptions: Setting the Safety Bar for Clinical AI
Brian P. McDonough, MD, FAAFP
Suvrankar Datta, MD
Turning Insight into Action: The Expanding Role of Medical Affairs
MAPSChatsTurning Insight into Action: The Expanding Role of Medical Affairs
Matt Birnholz, MD
Michael DeLuca, PharmD, MBA, MSRA
CME
Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
CME/CEEngineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
C. Michael Gibson, MD, MS
Valeria Caso, MD, PhD
Ashkan Shoamanesh, MD
SOHO 2026 Debrief: Translating the Latest CLL Data Into Community Practice Decisions
CME/CESOHO 2026 Debrief: Translating the Latest CLL Data Into Community Practice Decisions
Jennifer R. Brown, MD, PhD
Beyond Steroids in Warm AIHA: A Practical Framework for Diagnosis, Relapse Management, and Emerging Therapies
CME/CEBeyond Steroids in Warm AIHA: A Practical Framework for Diagnosis, Relapse Management, and Emerging Therapies
Caroline Piatek, MD
Anthony L. Nguyen, MD
- CME/CE In-Person & Virtual Event
22nd Annual Women’s Health Annual Visit (WHAV)
November 13, 2026
Pasadena, California Non-Obstructive HCM in Focus: Symptoms, Quality of Life, and Unmet Therapeutic Need
CME/CENon-Obstructive HCM in Focus: Symptoms, Quality of Life, and Unmet Therapeutic Need
Ahmad Masri, MD, MS
Michelle Michels, MD, PhD
Secondary Stroke Prevention in Focus: Addressing Residual Thrombotic Risk
CME/CE Broadcast ReplaySecondary Stroke Prevention in Focus: Addressing Residual Thrombotic Risk
Deborah Kerrigan, MD
Clay Johnston, MD
Industry Feature
Courtney Crawford, MD, FACS
Raj Maturi, MD
Groundbreaking Gene Therapy Restores Natural Hearing for Genetic Deafness
Medical Industry FeatureGroundbreaking Gene Therapy Restores Natural Hearing for Genetic Deafness
Lawrence Lustig, M.D.
Quick Takes in ATTR-CM: Diagnosis Barriers
Medical Industry FeatureQuick Takes in ATTR-CM: Diagnosis Barriers
Ola Akinboboye, MD, MBH, MBA
A Real-World CIDP Patient Journey: Perspectives From a Neuromuscular Specialist
Medical Industry FeatureA Real-World CIDP Patient Journey: Perspectives From a Neuromuscular Specialist
Shiv Bhadola, MD
What Is on the ‘HERIZON’ in 1L HER2+ Gastroesophageal Adenocarcinoma?
Medical Industry FeatureWhat Is on the ‘HERIZON’ in 1L HER2+ Gastroesophageal Adenocarcinoma?
Jennifer Caudle, DO, FACOFP
Syma Iqbal, MD
Applying a “Do No Harm” Mindset to Moderate-to-Severe Plaque Psoriasis Treatment Selection
Medical Industry FeatureApplying a “Do No Harm” Mindset to Moderate-to-Severe Plaque Psoriasis Treatment Selection
Charles Turck, PharmD, BCPS, BCCCP
Sam Awan, MD
Tina Bhutani, MD, MAS